ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Michigan » Psychiatry

Top Psychiatry Prescribers in Michigan

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
OLIN LEPARD M.D.

Psychiatry

30,555

$5.37M

1062
117 are 65+

1%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 24%

$176
Average prescription price

Avg: $140

NAGY KHEIR M.D.

Psychiatry

8,270

$1.02M

814
87 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 24%

$124
Average prescription price

Avg: $140

TODD ROSEN MD

Psychiatry

12,360

$2.05M

657
83 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 24%

$166
Average prescription price

Avg: $140

JOHN HEAD D.O>

Psychiatry

9,853

$1.24M

629
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 1%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 24%

$126
Average prescription price

Avg: $140

SOMESWARA NAVULURI MD

Psychiatry

5,440

$536K

568
48 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 24%

$99
Average prescription price

Avg: $140

MAZHUR MUNIR MD

Psychiatry

8,252

$1.11M

563
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 24%

$135
Average prescription price

Avg: $140

NILANJAN GAJARE M.D.

Psychiatry

11,675

$1.78M

512
78 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 24%

$152
Average prescription price

Avg: $140

MICHAEL GOTLIB M.D.

Psychiatry

3,881

$464K

473
39 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

2%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 24%

$120
Average prescription price

Avg: $140

KISHORE KONDAPANENI MD

Psychiatry

5,325

$588K

444
53 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 24%

$110
Average prescription price

Avg: $140

ABDULRAHMAN ZAHURULLAH MD

Psychiatry

7,374

$1.19M

430
38 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 24%

$161
Average prescription price

Avg: $140

GREGORY WASHINGTON MD

Psychiatry

5,157

$922K

422
45 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

30%
prescriptions for brand name drugs

Avg: 24%

$179
Average prescription price

Avg: $140

HON CHAN DO

Psychiatry

9,192

$997K

419
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 24%

$108
Average prescription price

Avg: $140

SITA RAMA PRASAD SAJJA M.D.

Psychiatry

4,929

$553K

416
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 24%

$112
Average prescription price

Avg: $140

MOHAMMED YOUSUF M.D.

Psychiatry

6,175

$1.04M

409
102 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 24%

$168
Average prescription price

Avg: $140

ABDUL HAFEEZ MD

Psychiatry

6,236

$1.17M

397
43 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 1%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 24%

$188
Average prescription price

Avg: $140

RONALD BRADLEY DO PHD

Psychiatry

4,786

$658K

393
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 24%

$138
Average prescription price

Avg: $140

GOPAL BEDI MD

Psychiatry

5,179

$734K

391
25 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 24%

$142
Average prescription price

Avg: $140

THEODORE RUZA DO PC

Psychiatry

4,569

$357K

387
356 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

31%
prescriptions for brand name drugs

Avg: 24%

$78
Average prescription price

Avg: $140

ASHA JAIN MD

Psychiatry

4,466

$732K

381
28 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 24%

$164
Average prescription price

Avg: $140

GARY RICH MD

Psychiatry

5,507

$579K

371
102 are 65+

18%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 24%

$105
Average prescription price

Avg: $140

NANCY DEVINE M.D.

Psychiatry

7,682

$1.2M

370
36 are 65+

24%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 24%

$156
Average prescription price

Avg: $140

RAVINDER MEDIRATTA M.D.

Psychiatry

9,573

$1.73M

369
75 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

30%
prescriptions for brand name drugs

Avg: 24%

$180
Average prescription price

Avg: $140

ERIC KUBRAK M.D.

Psychiatry

6,845

$1.33M

362
32 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 24%

$194
Average prescription price

Avg: $140

KALAPPURACKAL JOSEPH MD

Psychiatry

6,497

$751K

358
136 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 24%

$116
Average prescription price

Avg: $140

MICHAEL INGRAM MD

Psychiatry

4,399

$560K

348
58 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 24%

$127
Average prescription price

Avg: $140

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank